Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology across its operations as it looks to keep pace with rapid expansion in the ... Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds. New research suggests these GLP-1 medications could also help protect the heart after a heart ...

Context Explanation

Reuters on MSN: Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds NDTV on MSN: Ozempic might preserve lean body mass better than Mounjaro: Study Yahoo: I have a better alternative to Ozempic, and it will cost you nothing I have a better alternative to Ozempic, and it will cost you nothing Science Daily: Ozempic-like weight loss drugs may help the heart recover after a heart attack